Pulmonx Corp SEC filings LUNG

Pulmonx Corp has 450 filings in SEC EDGAR's recent list, going back to Dec 9, 2003. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.

Pulmonx Corp SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 27, 2026 Oct 27, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 4, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Mar 5, 2026 Mar 2, 2026
8-K Current report
Results of operations
Mar 4, 2026 Mar 4, 2026
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Results of operations, Officer or director change
Oct 27, 2025 Oct 21, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
8-K Current report
Shareholder vote results
May 23, 2025 May 22, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
8-K Current report
Results of operations
Feb 19, 2025 Feb 19, 2025
8-K Current report
Results of operations
Oct 30, 2024 Oct 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
8-K Current report
Material agreement
May 23, 2024 May 23, 2024
8-K Current report
Shareholder vote results
May 17, 2024 May 17, 2024
8-K Current report
Results of operations
May 1, 2024 May 1, 2024
8-K Current report
Officer or director change, Other events
Apr 2, 2024 Apr 2, 2024
8-K Current report
Results of operations
Feb 21, 2024 Feb 21, 2024
8-K Current report
Officer or director change, Other events
Feb 21, 2024 Feb 21, 2024
8-K Current report
Results of operations
Oct 30, 2023 Oct 30, 2023
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Oct 10, 2023 Oct 6, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Shareholder vote results
May 18, 2023 May 17, 2023
8-K Current report
Results of operations
May 2, 2023 May 2, 2023
8-K Current report
Results of operations, New debt
Feb 22, 2023 Feb 22, 2023
8-K Current report
Material agreement, Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Results of operations
Aug 2, 2022 Aug 2, 2022
8-K Current report
Shareholder vote results
May 27, 2022 May 26, 2022
8-K Current report
Results of operations
May 3, 2022 May 3, 2022
8-K/A Amended current report
Results of operations
Feb 25, 2022 Feb 23, 2022
8-K Current report
Results of operations
Feb 23, 2022 Feb 23, 2022
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
8-K Current report
Officer or director change
Aug 2, 2021 Jul 29, 2021
8-K Current report
Shareholder vote results
May 21, 2021 May 20, 2021
8-K Current report
Results of operations
May 4, 2021 May 4, 2021
8-K Current report
Officer or director change
Mar 24, 2021 Mar 22, 2021
8-K Current report
Results of operations
Mar 2, 2021 Mar 2, 2021
8-K Current report
Results of operations
Nov 10, 2020 Nov 10, 2020
8-K Current report
Bylaw or fiscal year change
Oct 5, 2020 Oct 5, 2020

Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
LUNG (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1127537
Former names
PULMONX (until Feb 7, 2012)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.